News
-
-
-
COMMUNIQUÉ DE PRESSE
BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets
BioNxt Solutions Inc. launches feasibility study for oral dissolvable film of Semaglutide, a GLP-1 receptor agonist, to improve patient experience and adherence. Study aims to assess compatibility and generate data for formulation optimization and patent strategy -
COMMUNIQUÉ DE PRESSE
Silver Tiger Metals: Mexico's next big silver mine?
Silver Tiger Metals is set to become Mexico's next big silver mine with over $120 million institutional financing and 200 million ounces of silver equivalent. CEO Glenn Jessome explains the key factors for success in the mining sector -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease
New peer-reviewed data supports masitinib's potential for treating Alzheimer's disease through cognitive enhancement and neuroprotection. Phase 3 study authorized by FDA and key EU countries
